Citadel Advisors LLC 13D/13G Filings for VYNE Therapeutics Inc. (VYNE)

Citadel Advisors LLC 13D and 13G filings for VYNE Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
4:57 pm
Sale		 2023-12-31 13G VYNE Therapeutics Inc.
VYNE		 Citadel Advisors LLC 1,181,144
8.500%		 -23decrease
(-0.00%)		 Filing
2023-11-13
4:41 pm
Purchase		 2023-11-01 13G VYNE Therapeutics Inc.
VYNE		 Citadel Advisors LLC 1,181,167
8.500%		 1,181,167increase
(New Position)		 Filing